These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 2121721

  • 1. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
    Kawashima I, Tada N, Fujimori T, Tai T.
    J Biochem; 1990 Jul; 108(1):109-15. PubMed ID: 2121721
    [Abstract] [Full Text] [Related]

  • 2. Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin.
    Honsik CJ, Jung G, Reisfeld RA.
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7893-7. PubMed ID: 3094017
    [Abstract] [Full Text] [Related]

  • 3. Activation of cellular cytotoxicity and complement-mediated lysis of melanoma and neuroblastoma cells in vitro by murine antiganglioside antibodies MB 3.6 and 14.G2a.
    Mayer P, Handgretinger R, Bruchelt G, Schaber B, Rassner G, Fierlbeck G.
    Melanoma Res; 1994 Apr; 4(2):101-6. PubMed ID: 8069095
    [Abstract] [Full Text] [Related]

  • 4. Analysis of a murine anti-ganglioside GD2 monoclonal antibody expressing both IgG2a and IgG3 isotypes: monoclonality, apoptosis triggering, and activation of cellular cytotoxicity on human melanoma cells.
    Lin CC, Shen YC, Chuang CK, Liao SK.
    Adv Exp Med Biol; 2001 Apr; 491():419-29. PubMed ID: 14533812
    [Abstract] [Full Text] [Related]

  • 5. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
    Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo K.
    J Cell Biol; 1986 Mar; 102(3):688-96. PubMed ID: 3005335
    [Abstract] [Full Text] [Related]

  • 6. Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model.
    Helfand SC, Soergel SA, Donner RL, Gan J, Hank JA, Lindstrom MJ, Sondel PM.
    J Immunother Emphasis Tumor Immunol; 1994 Oct; 16(3):188-97. PubMed ID: 7834118
    [Abstract] [Full Text] [Related]

  • 7. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.
    Mujoo K, Kipps TJ, Yang HM, Cheresh DA, Wargalla U, Sander DJ, Reisfeld RA.
    Cancer Res; 1989 Jun 01; 49(11):2857-61. PubMed ID: 2720646
    [Abstract] [Full Text] [Related]

  • 8. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
    Kusano A, Ohta S, Shitara K, Hanai N.
    Anticancer Res; 1993 Jun 01; 13(6A):2207-12. PubMed ID: 8297135
    [Abstract] [Full Text] [Related]

  • 9. Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.
    Chen RL, Reynolds CP, Seeger RC.
    Cancer Immunol Immunother; 2000 Feb 01; 48(11):603-12. PubMed ID: 10663607
    [Abstract] [Full Text] [Related]

  • 10. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I, Yoshida Y, Taya C, Shitara H, Yonekawa H, Karasuyama H, Tada N, Furukawa K, Tai T.
    Int J Oncol; 2003 Aug 01; 23(2):381-8. PubMed ID: 12851687
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
    Thurin J, Thurin M, Kimoto Y, Herlyn M, Lubeck MD, Elder DE, Smereczynska M, Karlsson KA, Clark WM, Steplewski Z.
    Cancer Res; 1987 Mar 01; 47(5):1229-33. PubMed ID: 3815333
    [Abstract] [Full Text] [Related]

  • 12. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.
    Kushner BH, Cheung NK.
    Blood; 1989 May 15; 73(7):1936-41. PubMed ID: 2653466
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma.
    Munn DH, Cheung NK.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6600-5. PubMed ID: 3499978
    [Abstract] [Full Text] [Related]

  • 14. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
    Tai T, Kawashima I, Tada N, Dairiki K.
    J Biochem; 1988 Apr 15; 103(4):682-7. PubMed ID: 3170507
    [Abstract] [Full Text] [Related]

  • 15. Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes.
    Kushner BH, Cheung NK.
    Cancer Res; 1991 Sep 15; 51(18):4865-70. PubMed ID: 1654202
    [Abstract] [Full Text] [Related]

  • 16. Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8.
    Zhao Q, Ahmed M, Guo HF, Cheung IY, Cheung NK.
    J Biol Chem; 2015 May 22; 290(21):13017-27. PubMed ID: 25851904
    [Abstract] [Full Text] [Related]

  • 17. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
    Zeng Y, Fest S, Kunert R, Katinger H, Pistoia V, Michon J, Lewis G, Ladenstein R, Lode HN.
    Mol Immunol; 2005 Jul 22; 42(11):1311-9. PubMed ID: 15950727
    [Abstract] [Full Text] [Related]

  • 18. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
    Harel W, Shau H, Hadley CG, Morgan AC, Reisfeld RA, Cheresh DA, Mitchell MS.
    Cancer Res; 1990 Oct 01; 50(19):6311-5. PubMed ID: 2400994
    [Abstract] [Full Text] [Related]

  • 19. Immunorecognition of ganglioside epitopes: correlation between affinity and cytotoxicity of ganglioside antibodies.
    Dippold W, Bernhard H.
    Eur J Cancer; 1992 Oct 01; 28A(10):1605-10. PubMed ID: 1382491
    [Abstract] [Full Text] [Related]

  • 20. New anti-GD2 monoclonal antibodies produced from gamma-interferon-treated neuroblastoma cells.
    Gross N, Beck D, Portoukalian J, Favre S, Carrel S.
    Int J Cancer; 1989 Apr 15; 43(4):665-71. PubMed ID: 2467885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.